Use of Telemedicine to Increase Thrombolysis and Advance Care in Acute Ischemic Stroke

The use of the only proven therapy for acute ischemic stroke, intravenous tissue plasminogen activator (tPA), remains disappointingly low. One potential way to increase the use of tPA is by the implementation of telemedicine stroke care networks. Preliminary data from several studies indicate that t...

Full description

Saved in:
Bibliographic Details
Published inCerebrovascular diseases (Basel, Switzerland) Vol. 27; no. Suppl 4; pp. 9 - 14
Main Authors Henninger, Nils, Chowdhury, Nabi, Fisher, Marc, Moonis, Majaz
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.06.2009
Subjects
Acute Disease
Brain Ischemia - complications
Humans
Stroke - etiology
Stroke - therapy
Telemedicine
Telemedicine - trends
Thrombolytic Therapy - trends
Thrombolytic Therapy - utilization
Telemedicine
Acute ischemic stroke
Thrombolysis
Online AccessGet full text

Cover

More Information
Summary:The use of the only proven therapy for acute ischemic stroke, intravenous tissue plasminogen activator (tPA), remains disappointingly low. One potential way to increase the use of tPA is by the implementation of telemedicine stroke care networks. Preliminary data from several studies indicate that the safe and expanded use of tPA for ischemic stroke can be accomplished with the help of telemedicine. Telemedicine stroke care networks can also be used in the future to enhance stroke diagnosis with advanced CT and MRI technology and to potentially increase the number of patients referred to tertiary stroke centers for intra-arterial therapies. It is highly likely that telemedicine stroke care will substantially enhance acute stroke therapy for remote and underserved populations.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISBN:3805591551
9783805591553
ISSN:1015-9770
1421-9786
DOI:10.1159/000213053